Mayne Pharma Group is a specialty pharmaceutical company based in Australia that develops, manufactures and markets prescription medicines. Its portfolio includes generic and branded products in areas such as women's health, dermatology and oral drug delivery, and it supplies pharmacies, hospitals and healthcare providers in Australia and overseas. The company also provides contract development and manufacturing services for other pharmaceutical firms, making tablets, capsules and other dose forms at its production sites.
The shares are listed on the Australian Securities Exchange in Australia under the code MYX, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #836 of 1815 on the Australian Securities Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Australia yet.
TrendFair
60/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-5.3%
From 52-week high-58.9%
MomentumWeak
43/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-7.9%
6-month return-1.5%
12-month, skipping last month-52.2%
Stability (higher is calmer)Weak
42/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)70.7%
Worst drawdown, 1 year (smaller is calmer)-65.6%
LiquidityStrong
77/100
Trades actively.
See the numbers →
Avg daily value traded0.70M AUD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends1
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Australia when fundamentals data for this market is added. All Australia stocks.
52-wk range 2.040 – 6.320Daily closes, split-adjusted
Signals
50-day average2.982
200-day average2.692
Golden/death cross (60d)Golden, 39 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.117
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
2.64
Bearish
EMA 10
2.63
Bearish
SMA 20
2.75
Bearish
EMA 20
2.73
Bearish
SMA 50
2.98
Bearish
EMA 50
2.84
Bearish
SMA 100
2.82
Bearish
EMA 100
2.85
Bearish
SMA 200
2.69
Bearish
EMA 200
3.04
Bearish
Oscillators (daily)
RSI (14)
36.77
Neutral
MACD (12, 26)
-0.12
Bearish
Momentum (12)
-10.53
Bearish
Stochastic %K (14)
12.77
Bullish
Williams %R (14)
-87.23
Bullish
CCI (20)
-114.7
Bullish
Pivot points (classic, last session)
S3
2.43
S2
2.47
S1
2.51
Pivot
2.56
R1
2.60
R2
2.64
R3
2.68
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 AUD
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
18 Jan 2023
0.5440
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in AUD. Educational only, not financial advice.
